Showing 1671-1680 of 2314 results for "".
- Mundipharma Donates Betadine Products to Hospitals in Philippines, Thailand and Vietnam to Support the Fight Against COVID-19https://modernod.com/news/mundipharma-donates-betadine-products-to-hospitals-in-philippines-thailand-and-vietnam-to-support-the-fight-against-covid-19/2477539/Mundipharma has donated supplies of its Betadine range of products to hospitals in Philippines, Thailand and Vietnam to support the efforts of healthcare professionals amidst the outbreak. Th
- BVI Donating Personal Protective Equipment to Help Protect the COVID-19 Frontlinehttps://modernod.com/news/bvi-donating-personal-protective-equipment-to-help-protect-the-covid-19-frontline/2477520/In a statement posted on its website, BVI stated that it is repurposing its products and redirecting supplies toward the COVID-19 response. It is also donating personal protective equipment (PPE) to health care facilities in hard hit areas. The statement reads: “COVID-19 is im
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- Bausch Health Donates Health Care Products And Supplies In Response To COVID-19 Pandemichttps://modernod.com/news/bausch-health-donates-health-care-products-and-supplies-in-response-to-covid-19-pandemic/2477458/Bausch Health Companies outlined several initiatives the company is taking to contribute to the fight against COVID-19. “Bausch Health is actively donating medicines and health care products to assist
- American College of Surgeons Releases New Clinical Guidance Document For Elective Surgical Case Triage During COVID-19https://modernod.com/news/american-college-of-surgeons-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19/2477456/To assist in surgical decision-making in curtailing cases, The American College of Surgeons (ACS) released “COVID-19: Elective Case Triage Guidelines for Surgical Care,” a new surgical triage document that was developed following expert review in several specialties and provides trust
- Doctors Turn to Malaria Drugs as Potential Coronavirus Treatmenthttps://modernod.com/news/doctors-turn-to-malaria-drugs-as-potential-coronavirus-treatment/2477434/Doctors and hospitals are turning to chloroquine phosphate and hydroxychloroquine to treat patients infected with COVID-19, as the antimalarial drugs have both shown early signs of improving symptoms of some patients diagnosed with COVID-19, based on reports by doctors and researchers in South Ko
- Bayer Partners With U.S. Government on Major Product Donation to Fight Coronavirushttps://modernod.com/news/bayer-partners-with-u-s-government-on-major-product-donation-to-fight-coronavirus/2477417/Bayer announced it is joining the U.S. Government’s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate). Resochin, a product discovered by Bayer in 1934 and indicated for prevention and treatment of malaria, also appears to have br
- First Patient Dosed in Study of Moderna’s mRNA Vaccine Against COVID-19https://modernod.com/news/first-patient-dosed-in-study-of-modernas-mrna-vaccine-against-covid-19/2477403/Moderna announced that the first subject has been dosed in a phase 1 study of its experimental mRNA vaccine mRNA-1273 against SARS-CoV-2. The phase 1 trial, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle,
- AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical Trials in Patients with Achromatopsiahttps://modernod.com/news/agtc-announces-completion-of-enrollment-in-all-adult-dose-groups-of-its-ongoing-phase-1-2-clinical-trials-in-patients-with-achromatopsia/2477389/Applied Genetic Technologies Corporation (AGTC) announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including the two higher dose groups, of its phase 1/2 clinical programs with achromatopsia due to mutation in the